AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 51 filers reported holding AMBRX BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 1.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 16,688,636 | $191,919,314 | 67.54% |
| Cormorant Asset Management, LP | 9,923,689 | $114,122,424 | 6.66% |
| COMMODORE CAPITAL LP | 3,518,556 | $40,463,394 | 4.73% |
| Ally Bridge Group (NY) LLC | 281,089 | $3,232,524 | 3.79% |
| Paradigm Biocapital Advisors LP | 3,488,596 | $40,118,854 | 2.72% |
| VR Adviser, LLC | 2,070,000 | $23,805,000 | 2.51% |
| Ghost Tree Capital, LLC | 525,000 | $6,037,500 | 1.99% |
| HighVista Strategies LLC | 193,701 | $2,227,562 | 1.03% |
| Ikarian Capital, LLC | 4,932 | $5,671,800 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 34,000 | $391,000 | 0.51% |
| Monashee Investment Management LLC | 70,000 | $805,000 | 0.34% |
| Parkman Healthcare Partners LLC | 150,000 | $1,725,000 | 0.32% |
| GREAT POINT PARTNERS LLC | 97,700 | $1,123,550 | 0.20% |
| Logos Global Management LP | 115,000 | $1,322,500 | 0.18% |
| Paradigm Biocapital Advisors LP | 209,600 | $2,410,400 | 0.16% |
| INNOVIS ASSET MANAGEMENT LLC | 31,137 | $358,076 | 0.14% |
| NWI MANAGEMENT LP | 160,935 | $1,851 | 0.09% |
| FEDERATED HERMES, INC. | 2,395,867 | $27,552,471 | 0.07% |
| ExodusPoint Capital Management, LP | 493,393 | $5,674 | 0.05% |
| D. E. Shaw & Co., Inc. | 4,004,513 | $46,051,900 | 0.05% |
External links
This page lists AMBRX BIOPHARMA INC's shareholders in Q3 2023. To view AMBRX BIOPHARMA INC's shareholder history, click here.